Q&A

Now & Next: Mavupharma

Source: Jubilant Biosys
Genomic Laboratory Services

Saurabh Kapure,  Vice President, Business  Development,  USA  for  Jubilant Biosys, recently sat down with Michael Gallatin, Ph.D. president and co-founder of Mavupharma (Mavu), the drug discovery and development company, to discuss some of the latest developments in the industry and at Mavu. They chatted for about an hour. During that time, Dr. Gallatin shared his thoughts about Mavupharma, his role at the company, the evolution of biopharma, drug discovery, development, and the road ahead for the industry with Saurabh. The following Q&A, which has been lightly edited for clarity and length, are some key excerpts from their conversation.

VIEW THE Q&A!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: